Does DEUCRAVACITINIB Cause Condition aggravated? 27 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Condition aggravated have been filed in association with DEUCRAVACITINIB (SOTYKTU). This represents 1.1% of all adverse event reports for DEUCRAVACITINIB.
27
Reports of Condition aggravated with DEUCRAVACITINIB
1.1%
of all DEUCRAVACITINIB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Condition aggravated From DEUCRAVACITINIB?
Of the 27 reports, 1 (3.7%) resulted in death, 1 (3.7%) required hospitalization, and 1 (3.7%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEUCRAVACITINIB. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does DEUCRAVACITINIB Cause?
Drug ineffective (228)
Acne (225)
Pruritus (187)
Rash (175)
Erythema (124)
Psoriasis (122)
Off label use (101)
Adverse event (74)
Mouth ulceration (72)
Folliculitis (65)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which DEUCRAVACITINIB Alternatives Have Lower Condition aggravated Risk?
DEUCRAVACITINIB vs DEUTETRABENAZINE
DEUCRAVACITINIB vs DEUTIVACAFTOR\TEZACAFTOR\VANZACAFTOR
DEUCRAVACITINIB vs DEVICE
DEUCRAVACITINIB vs DEXAMETHASONE
DEUCRAVACITINIB vs DEXAMETHASONE\DEXAMETHASONE